384results about How to "Accurate medication" patented technology

The invention discloses a drug for treating osteoporosis, and particularly relates to an oral dripping pill preparation prepared by adopting calcitriol as raw material. The invention aims at making up the defects that the existing preparation formulation is little and the drug is not stable and providing an oral dripping pill preparation with high bioavailability, fast drug releasing, fast effect, high drug content, good stability of drug, convenient taking and no pollution in production. The calcitriol dripping pill adopts calcitriol as raw material and is prepared with carrier which is pharmaceutically acceptable and used as matrix.

The invention relates to a medicine taking reminding medical kit which comprises a kit body, an identity recognition module, a processing module, a communication module, a prompt module and a control module. The kit body comprises a plurality of kit cells, and each kit cell correspondingly stores one kind of medicine and corresponds to one kit cell number; the identify recognition module is used for obtaining identity information of a medicine user; the control module transmits the identity information to a server through the communication module; the server pre-stores medicine use information corresponding to the identity information and feeds back the medicine use information corresponding to the identity information to the medicine kit; the processing module processes the medicine use information and generates prompt information; the control module controls the prompt module to broadcast the kit cell numbers and dosage corresponding to the kit cell numbers according to the prompt information.

The invention provides a medication use guidance method, a medication use guidance device and an electronic device, relates to the technical field of medical treatment. The medication use guidance method comprises the steps of obtaining a medication use condition of a user, wherein the medication use condition comprises target medicines required by a user; determining a relevant gene of each target medicine based on the medication use condition; finding a medication use characteristic corresponding to the target medicines and the relevant genes of the user; and generating a medication use guidance scheme of the user based on the medication use characteristic. In the scheme, the generated medication use guidance scheme is determined by the gene of the user per se which is relevant to the medicines, and the medication use is more accurate.

Methods and systems for seamless adjustment of treatment are disclosed. A determination is made as to whether to intervene with a patient's treatment. Implanted device memory data is acquired over a pre-specified time period. Risk status is determined from the device memory data. Another external device memory data is acquired over a pre-specified time period. A determination is made as to whether to adjust treatment of the patient in response to the risk status, the data acquired from the implanted device memory and the external device memory data.

A medication recording apparatus is used for motoring and recording patient's medication. The medication recording apparatus is coupled with a drug inhaler. When the patient receives a drug from the drug inhaler, a drug-supply actuation is generated. The medication recording apparatus has: a sensing module for sensing at least one type of the medication recording apparatus motion generated by the drug-supply actuation and sensing a motion data generated by the drug-supply actuation; a control and analysis module for determining if the medication recording apparatus motion is a valid medication according to the motion data and recording correct medication information corresponding to the correct medication. A medication recording method is also provided and used to analyze if the drug-supply actuation of the patient generates the valid medication and to record the correct medication information, so as to control the patient's medication status.

The invention discloses an agricultural internet-of-things system based on big data. According to different levels of information generation, transmission, processing and application, the system comprises a sensing layer, a transmitting layer, a processing layer and an application layer and is used for doing a data obtaining task. Environment parameters, crop growth and development states and device running state data information are collected through various sensor devices deployed in a large field. The running state data information further includes the temperature, humidity, carbon dioxideconcentration, illumination intensity, heating temperature, wind speed, wind direction, rainfall, frost and windstorm. According to the agricultural internet-of-things system based on big data, a traditional extensive production mode is broken, agricultural production is developed into intensification, precision, intelligence and datamation, and the functions of precise fertilizer applying, precise drug applying, automatic yield testing, unmanned driving and the like are realized step by step.

The invention provides a construction method of a kidney transplantation anti-infection drug dosage prediction model. The method comprises the following steps: establishing a group pharmacokinetic model of an anti-infective drug by adopting a nonlinear mixed effect model, a two-atrioventricular model and a mixed residual model through plasma concentration analysis, and calculating pharmacokinetic parameters of the corresponding model; and carrying out related hypothesis testing and estimation on the obtained model pharmacokinetic parameters based on a bootstrap method, visual prediction testing and normalized prediction distribution errors, and completing the steps of stability and prediction capability evaluation and the like. According to the established pharmacokinetic model of the kidney transplantation patient population, the reasonable judgment on the medication scheme information is accurately realized, the reference of the optimal dosage is expected to be provided in the infection prevention and treatment process, the adverse reaction risk is reduced, the curative effect is improved, and finally the individualized administration of the anti-infection medicine of the kidney transplantation patient is realized.

The present invention relates to a method for simultaneous detection of the coagulation activity of a blood sample and of the presence and/or amount of at least one target molecule within said blood sample, comprising the steps of: i) introducing a blood sample into a sample container comprising magnetic particles and a sensor surface, wherein said magnetic particles are functionalized with a first binding molecule, wherein said first binding molecule is attached to said magnetic particles, wherein the first binding molecule is capable of specifically binding to the at least one target molecule within said blood sample, and wherein a second binding molecule is attached to a sensor surface at the bottom of said sample container, and wherein said second binding molecule of the sensor surface is capable of specifically binding to the at least one target molecule within said blood sample; ii) measuring the presence and/or amount of said target molecule by detecting the number of magnetic particles bound to said sensor surface; wherein the number of bound magnetic particles is directly or inversely related to the amount of said at least one target molecule present in the sample; iii) at the same time or at different times measuring the co-agulation activity of said blood sample, wherein said magnetic particles are magnetically actuated; and wherein the loss of mobility of said magnetic particles is detected by measuring the light reflected from said immobilized magnetic particles near or at said sensor surface; and wherein the change of detected light signal is indicative of an increase of viscosity and/or a clotting of the blood sample; and wherein the magnetic particles in steps i) to iii) are magnetically actuated using a magnetic field generator.

The invention provides a drug management method and device based on disease monitoring. The method is applied to an intelligent client-side, wherein the intelligent client-side is in communication connection with an intelligent drug storage device. The method comprises the steps that real-time disease information of a user is obtained; according to the real-time disease information, real-time disease level information of the disease of the user is obtained; drug information corresponding to the disease is obtained; drug instruction information is obtained; according to the disease level information and the drug instruction information, administration information of the user is determined; according to the administration information, first remind information is obtained, wherein the first remind information is used for reminding the user to take the corresponding drug according to the administration information; according to the administration information, second remind information is sent to the intelligent drug storage device, wherein the second remind information is used for making the intelligent drug storage device issue remind information. The technical effect is achieved thatthe condition of the patient is monitored in real time, and the drug is taken precisely according to the condition.

The invention discloses a medicinal composition for treating urinary lithiasis, pyelonephritis and cholecystitis, especially snowbell-leaf tickclover dripping pills and its preparation method, wherein the dripping pills are prepared from snowbell-leaf tickclover, and medicinal carrying agent as the base material. The dripping pills have the advantages of high biological availability, quick-speed medicine release, quick-speed effect, higher medicinal content, easy administering, low price, and no contamination in production.

The invention discloses a drug sensitivity kit, a preparing method thereof and a bacterium drug sensitivity detection method. The drug sensitivity kit comprises a box body, a culture medium slab, scraps of paper of drug sensitivity and a testing apparatus, the box body is internally provided with an accommodation cavity, the culture medium slab is arranged in the accommodation cavity and comprisesa common nutrient agar slab, a MacConkey agar slab, an SS agar slab and a tryptic soytone broth agar slab containing a coenzyme A, the scraps of paper of drug sensitivity are arranged in the accommodation cavity, and each scrap of paper of drug sensitivity correspondingly contains any one of tulathromycin, acetyl-isovaleryl tulathromycin, valnemulin, levofloxacin, lomefloxacin, ciprofloxacin, enrofloxacin, gentamicin, kanamycin, streptomycin, tylosin, tilmicosin, spectinomycin, florfenicol, ceftiofur, tiamulin, doxycycline, colistin, amoxicillin and lincomycin. The drug sensitivity kit has the advantages that the testing result is precise, the consumed time is short, the operation is simple, and the cost is low.

A system and method for positioning a pill to be ingested by a user in a field of view of an image acquisition camera. The method includes the steps of determining a desired location of the mouth of a user in a field of view of an image acquisition camera, determining a current position of a pill to be ingested by the user in the field of view of the image acquisition apparatus, and indicating on a display a movement to be made by the user to move the pill towards mouth of the user.

The invention relates to a Lllicium henryi drop pill, which is a medicinal composition having the functions of repercussion, removing stasis, promoting blood circulation, relieving pain, treating waist and knee strain, articular muscle desmodynia and rheumatalgia. The aim of the invention is to provide a medicinal composition having the advantages of high biological availability, quick-speed medicine release, quick-speed effect, higher medicinal content, accurate administration dosage, low price, no acute allergic reaction or adverse effect, and facilitated transportation and carrying. The drop pill is prepared from traditional Chinese herb of Lllicium henryi as raw material, and medicinal carrying agent as the base material.

A Chinese medicine in the form of effervescent tablet for treating cough and resolving sputum is prepared from 8 Chinese-medicinal materials including pummelo peel, bitter almond, liquorice root, etc and 3 medicinal additives: citric acid, dicarbonate and polyethanediol.

A Chinese medicine in the form of dripping pill for treating coronary arteriosclerotic heart disease, thromboangiitis obliterans, central retinitis, infantile pneumonia, etc is prepared from pubescent holly root and medicinal carrier. Its preparing process is also disclosed.

The invention provides a formula of a human brain natriuretic peptide liquid preparation which comprises human brain natriuretic peptide 0.5 mg/ml, a buffer solution system, polysaccharide alcohol, amino acid and a salt compound. The invention further discloses a preparation method of the human brain natriuretic peptide liquid preparation. Through selecting auxiliary materials, the recombinant human brain natriuretic peptide liquid preparation has favorable stability and activity so that the safety and effectiveness of medication are ensured.

The invention provides a culture medium and a culture method for rapidly amplifying primary cells of esophageal squamous carcinoma in vitro and application of the culture medium and the culture method in medicine screening. The culture medium for the primary cells of the esophageal squamous carcinoma contains an initial culture medium, an Rho protease inhibitor, antibiotics, insulin, an N2 additive, an insulin-like growth factor 1, non-essential amino acid, optional hydrocortisone, optional glutamine and optional bovine pituitary extract.

The invention discloses a pymetrozine suspension seed coating agent and a preparation method of the pymetrozine suspension seed coating agent. The suspension seed coating agent comprises the following components by weight: 5-60 parts of pymetrozine, 3-30 parts of dispersing agent, 0.1-10 parts of stabilizing agent, 0.1-10 parts of film forming agent, 0.1-10 parts of antifoaming agent, 1-10 parts of anti-freezing agent, 0.1-10 parts of penetrating agent, 0.2-10 parts of preservative, and 0.5-10 parts of colouring agent, adding water to complement the number of the materials to be 100 parts. The pymetrozine suspension seed coating agent has the advantages of low toxicity, good pesticide effects, long duration, high safety and convenience in use, can reduce the environment pollution, improve the pesticide utilization rate, and reduce the usage amount of the pesticides.

The invention relates to the technical field of medical instruments, in particular to a respiratory medicine nursing drug dosing device comprising an injection mechanism, an occlusion disc and a guiding tube. One end of the guiding tube is connected and communicated with the injection mechanism, and the other end of the guiding tube penetrates a through hole formed in the occlusion disc for a patient to occlude. One end of the guiding tube away from the injection mechanism is provided with a first air bag and a second air bag. The first air bag and the second air bag are both communicated withan air guiding chamber disposed outside the guiding tube in the sleeve mode. The air guiding chamber is communicated with an air supply mechanism through a hard tube, a drug spraying head is arrangedbetween the first air bag and the second air bag, and a plurality of drug outlet holes communicated with the inside of the guiding tube are formed in the drug spraying head. The dosing device is novel in design, can inflate the first air bag and the second air bag through the air supply mechanism to enable the first air bag and the second air bag to expand to be attached to the respiratory tractto prevent the guiding tube from damaging the respiratory tract.

The invention discloses a man-machine data exchange and database management newborn monitoring bed which comprises a data acquisition module, a data communication and display module, a motor driving unit, a cell management module and a processing operation unit. The data acquisition module is connected with the processing operation unit; the data acquisition module is used for transmitting acquired newborn sign data to the processing operation unit to carry out operation processing; the data communication and display module is connected with the processing operation unit; the data communication and display module is used for transmitting a user instruction and carrying out corresponding display on the sign data subjected to processing operation by the processing operation unit; the motor driving unit is connected with the processing operation unit; the motor driving unit is used for regulating the height and the pitch angle of the monitoring bed according to a instruction sent out by the processing operation unit; the cell management module is connected with the processing operation unit; the cell management module is used for carrying out cell management by the processing operation unit.

The invention relates to a drug compound playing the role of diminishing inflammation, alleviating pain and eliminating fever and being used for treating arthritis, odynolysis and pyrexia caused by upper respiratory tract infection, and particularly relates to a drug compound oral pharmaceutical formulation adopting nimesulide as the ingredient and being prepared jointly with the medicinal carrier used as the stroma. The drug compound aims to supplement the deficiency of the prior oral nimesulide pharmaceutical formulation and provide a drug compound oral formulation, sustained-release nimesulide dropping pill which has high bioavailability, controllable release time, long-acting effect, reduced frequency of drug taking for a patient, low cost and absence of contamination during the production. The sustained-release nimesulide dropping pill adopts nimesulide as the chemical ingredient and is prepared jointly with the medicinal carriers of hydrophilic frame ingredients and hydrophobic frame ingredients used as the stroma.

A Chinese medicine in the form of dripping pill for treating pharyngolaryngitis, tonsillitis, sore throat, stomatitis, gingivitis, etc is prepared from 4 Chinese-medicinal materials including subprostrate sophora root, ciccada slough, menthol, etc. Its preparing process is also disclosed.